By nuvalore GmbH
Nuvalore to Present Advanced Pharma Analytics at POWTECH TECHNOPHARM
Leimen, Germany: – nuvalore GmbH, an independent, GMP- and ICH- compliant analytical contract laboratory serving the pharmaceutical and life sciences sector, will attend the upcoming POWTECH TECHNOPHARM expo, where the Founder and Managing Director, Dr. Anamarija Ćurić, will give a presentation highlighting the company’s analytical expertise.
nuvalore will exhibit at Booth 9-111F, Hall 9.0 of the Nürnberg Messe, presenting its advanced analytical, validation, and quality assurance solutions for the life sciences industries.
Driving Efficiency and Quality in Pharmaceutical Analysis with DoE
nuvalore Founder and Managing Director, Dr. Anamarija Ćurić will speak at the Technopharm Forum (Day Two, Hall 10.0, Booth 10-356, 12:30 – 13:00 CET) on “Strategic Path to Success: DoE in Pharmaceutical Analytics.”
Dr. Ćurić will explain how Design of Experiments (DoE) has become an essential tool for efficient and reliable pharmaceutical analysis, particularly in biologics. She will outline an Analytical Quality by Design (AQbD) 90-day workflow, demonstrating how DoE helps define and optimize Critical Method Parameters (CMPs). By enabling researchers to examine multiple factors simultaneously with fewer experiments, using full or fractional factorial approach to creates robust design spaces, accelerates development, and improves data quality.
Dr. Ćurić will also share case studies, including a Ligand-Binding Assay optimized with DoE that delivered 133 assays with zero failures, and an imaged capillary isoelectric focusing (icIEF) study that reduced the number of experiments needed to optimize a monoclonal antibody in half. These examples illustrate how integrating DoE within an AQbD framework, supported by ICH Q14 and Q2(R2) guidelines, delivers robust, cost-effective analytical solutions for pharmaceutical development.
About nuvalore GmbH
nuvalore GmbH is a contract quality control laboratory based in Leimen, Germany, specializing in the analytical characterization of pharmaceuticals and biopharmaceuticals. Founded in 2024, the company has quickly established a reputation for excellence in analytical method development, validation, quality assurance, and consultancy services for the pharmaceutical and life sciences industries.
nuvalore’s portfolio includes Analytical Quality by Design (AQbD), method development and transfer using Design of Experiments (DoE), and a broad range of product characterization services such as pharmacopeial quality control, protein and surfactant analysis, ELISA, nanoparticle measurement, and testing of primary packaging and delivery systems.
With a vision derived from its name — combining the Italian words nuovo (new) and valore (value) — nuvalore creates “new value” by linking science and quality. Its mission is to act as a trusted partner, applying innovative approaches and cutting-edge technologies to accelerate the safe, compliant market entry of client projects.
Privately held and headquartered in Germany, nuvalore operates to the highest regulatory standards, with a QMS aligned to GMP- and ICH- guidelines and is a member of BioRN and Pharma Deutschland.
To learn more, visit: www.nuvalore.com
About POWTECH TECHNOPHARM 2025
POWTECH TECHNOPHARM is the evolution of the POWTECH International Trade Fair for Mechanical Processing Technologies that was founded in 1971 and has since become the central node in a franchise of international events for processing, analysis and handling of powder, granule and bulk solids technologies under the PROCESSING ALLIANCE banner.
POWTECH TECHNOPHARM 2025 is a three-day event opening 23 September 2025 at the Nuremberg Messe Exhibition Centre. This year’s edition is designed as a door-opener to the European market, bringing equipment makers, system integrators, and process engineers together with pharma, food, chemical, battery, and recycling players.
It will feature live machinery demos and product launches, with a conference programme emphasizing process safety, containment, hygiene design, digitalization, and energy efficiency, plus pharma-specific tracks curated with sector bodies. The parallel PARTEC congress focuses on particle technology. The show is further co-located with FACHPACK, the European trade fair for packaging, creating an end-to-end view from processing through to packaging and logistics across adjacent halls.
The event is organized by Nürnberg Messe through the PROCESSING ALLIANCE, with further information at: https://www.powtech-technopharm.com/en
Resources
Click on Meet nuvalore at POWTECH TECHNOPHARM 2025 to connect with exhibitor home page.





